DrCarney.com Blog
Health - Food - Science - Community
1 minute reading time
(90 words)
Trajectories of alcohol consumption during life and the risk of developing breast cancer
A lifetime of alcohol consumption may favor the development of breast cancer in women.
This study looked at the connection between long-term usage of alcohol and a woman's odds of developing breast cancer. Researchers matched alcohol drinking habits with the occurrence of breast cancer among 2,500 Spanish women.
Researchers noted that breast cancer diagnoses were high among women who were generous consumers of alcohol for years. This study concluded that the greater the amount and duration of alcohol intake, the higher a woman's chances of being diagnosed with breast cancer.
Research Summary Information
-
2021
-
Carolina Donat-Vargas, Ángel Guerrero-Zotano, Ana Casas, José Manuel Baena-Cañada, Virginia Lope, Silvia Antolín, José Ángel Garcia-Saénz, Begoña Bermejo, Montserrat Muñoz, Manuel Ramos, Ana de Juan, Carlos Jara Sánchez, Pedro Sánchez-Rovira, Antonio Antón, Joan Brunet, Joaquín Gavilá, Javier Salvador, Esperanza Arriola Arellano, Susana Bezares, Nerea Fernández de Larrea-Baz, Beatriz Pérez-Gómez, Miguel Martín, Marina Pollán
-
IMDEA-Food Institute, CEI UAM+CSIC, Madrid, Spain. Department of Preventive Medicine and Public Health, School of Medicine, Universidad Autónoma de Madrid-IdiPaz, CIBERESP (CIBER of Epidemiology and Public Health), Madrid, Spain. Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. Medical Oncology Unit, Instituto Valenciano de Oncología, Valencia, Spain. Medical Oncology Unit, Hospital Virgen del Rocío, Sevilla, Spain. Medical Oncology Unit, Hospital Puerta del Mar, Cádiz, Spain. Instituto de Investigación en Biomedicina de Cádiz (INiBICA), Cádiz, Spain.National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain. Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain. Medical Oncology Unit, Complejo Hospitalario Universitario, A Coruña, Spain. Medical Oncology Unit, Hospital Clínico Universitario San Carlos, Madrid, Spain. Medical Oncology Unit, Hospital Clínico, Valencia, Spain. Medical Oncology Unit, Hospital Clinic i Provincial, Barcelona, Spain. Translational Genomics and Targeted Therapeutics, Institut d'Investigacions Biomèdiques Pi i Sunyer-IDIBAPS, Barcelona, Spain. Medical Oncology Unit, Centro Oncológico de Galicia, A Coruña, Spain. Medical Oncology Unit, Hospital Marqués de Valdecilla, Santander, Spain. Medical Oncology Unit/Departamento Especialidades Médicas, Hospital Universitario Fundación Alcorcón/Universidad Rey Juan Carlos, Madrid, Spain. Medical Oncology Unit, Hospital Universitario de Jaén, Jaén, España. Medical Oncology Unit, Hospital Universitario Miguel Servet, Zaragoza, España. Medical Oncology Department, Institut Català d'Oncologia, IDIBGi, Girona, Spain. Medical Sciences Department, Universitat de Girona, Girona, Spain. GEICAM Spanish Breast Cancer Research Group, Madrid, Spain. Medical Oncology Unit, Instituto de Investigación Sanitaria Gregorio Marañón/Universidad Complutense, Madrid, Spain. Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. Department of Preventive Medicine and Public Health, School of Medicine, Universidad Autónoma de Madrid-IdiPaz, CIBERESP (CIBER of Epidemiology and Public Health), Madrid, Spain. mpollan@isciii.es. National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain. mpollan@isciii.es. Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain. mpollan@isciii.es.
-
Yes, Free full text of study was found:
Stay Informed
When you subscribe to the blog, we will send you an e-mail when there are new updates on the site so you wouldn't miss them.
About the author
